Cargando…
Virus structure and structure-based antivirals
Structure-based antiviral developments in the past two years have been dominated by the structure determination and inhibition of SARS-CoV-2 proteins and new lead molecules for picornaviruses. The SARS-CoV-2 spike protein has been targeted successfully with antibodies, nanobodies, and receptor prote...
Autores principales: | Plavec, Zlatka, Pöhner, Ina, Poso, Antti, Butcher, Sarah J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460353/ https://www.ncbi.nlm.nih.gov/pubmed/34564030 http://dx.doi.org/10.1016/j.coviro.2021.09.005 |
Ejemplares similares
-
Machine Learning-Boosted
Docking Enables the Efficient
Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical
Libraries
por: Sivula, Toni, et al.
Publicado: (2023) -
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021) -
Structural Studies Reveal that Endosomal Cations Promote Formation of Infectious Coxsackievirus A9 A-Particles, Facilitating RNA and VP4 Release
por: Domanska, Aušra, et al.
Publicado: (2022) -
SARS-CoV-2 Production, Purification Methods and UV Inactivation for Proteomics and Structural Studies
por: Plavec, Zlatka, et al.
Publicado: (2022) -
Structure of POPC
Lipid Bilayers in OPLS3e Force Field
por: Kurki, Milla, et al.
Publicado: (2022)